ANI Pharmaceuticals Inc Financial Flexibility Index
ANI Pharmaceuticals Inc financial flexibility index. ANI Pharmaceuticals Inc (ANIP) has a Financial Flexibility Index of 0.06x as of December 2025. Free cash flow of $54.23 Million (operating CF $30.37 Million minus capex $23.86 Million) represents 0% of total liabilities ($899.65 Million). Explore ANIP capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of ANI Pharmaceuticals Inc (1998–2025)
Financial flexibility index of ANI Pharmaceuticals Inc from 1998 to 2025. Historical Financial Flexibility Index trend for ANI Pharmaceuticals Inc across 28 annual periods. Check ANI Pharmaceuticals Inc cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
ANI Pharmaceuticals Inc Financial Flexibility Index by Year (1998–2025)
ANI Pharmaceuticals Inc financial flexibility index by year from 1998 to 2025. Year-by-year free cash flow to debt coverage for ANI Pharmaceuticals Inc. For the full cash flow conversion analysis, see how efficiently does ANI Pharmaceuticals Inc generate cash.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.22x | $199.06 Million | $185.22 Million | $899.65 Million | ▲ +133.7% |
| 2024 | 0.09x | $80.97 Million | $64.02 Million | $855.17 Million | ▼ -69.2% |
| 2023 | 0.31x | $137.47 Million | $118.96 Million | $446.82 Million | ▲ +979.4% |
| 2022 | -0.03x | $-14.75 Million | $-31.20 Million | $421.55 Million | ▼ -153.6% |
| 2021 | 0.07x | $26.96 Million | $3.32 Million | $412.86 Million | ▼ -79.3% |
| 2020 | 0.31x | $83.59 Million | $15.27 Million | $265.49 Million | ▲ +5.0% |
| 2019 | 0.30x | $73.18 Million | $45.63 Million | $244.00 Million | ▼ -10.3% |
| 2018 | 0.33x | $77.99 Million | $67.07 Million | $233.34 Million | ▼ -46.2% |
| 2017 | 0.62x | $147.41 Million | $39.42 Million | $237.38 Million | ▼ -46.1% |
| 2016 | 1.15x | $176.53 Million | $27.47 Million | $153.22 Million | ▲ +188.8% |
| 2015 | 0.40x | $49.95 Million | $17.26 Million | $125.18 Million | ▼ -14.4% |
| 2014 | 0.47x | $57.79 Million | $22.03 Million | $123.92 Million | ▲ +131.2% |
| 2013 | -1.50x | $-5.29 Million | $-5.48 Million | $3.54 Million | ▲ +35.8% |
| 2012 | -2.33x | $-24.67 Million | $-25.28 Million | $10.59 Million | ▼ -21.3% |
| 2011 | -1.92x | $-47.15 Million | $-47.87 Million | $24.56 Million | ▼ -22.8% |
| 2010 | -1.56x | $-40.03 Million | $-40.10 Million | $25.62 Million | ▼ -76.3% |
| 2009 | -0.89x | $-18.27 Million | $-18.43 Million | $20.61 Million | ▲ +77.1% |
| 2008 | -3.86x | $-14.88 Million | $-15.54 Million | $3.85 Million | ▼ -861.1% |
| 2007 | 0.51x | $769.42K | $739.99K | $1.52 Million | ▲ +144.0% |
| 2006 | -1.15x | $-4.96 Million | $-5.00 Million | $4.30 Million | ▲ +61.4% |
| 2005 | -2.99x | $-8.23 Million | $-8.30 Million | $2.76 Million | ▲ +44.9% |
| 2004 | -5.42x | $-10.34 Million | $-10.44 Million | $1.91 Million | ▲ +13.3% |
| 2003 | -6.26x | $-5.51 Million | $-5.52 Million | $881.21K | ▼ -100.3% |
| 2002 | -3.12x | $-3.92 Million | $-3.96 Million | $1.26 Million | ▼ -66.8% |
| 2001 | -1.87x | $-1.74 Million | $-1.82 Million | $927.76K | ▲ +44.3% |
| 2000 | -3.36x | $-3.16 Million | $-3.21 Million | $941.26K | ▲ +38.0% |
| 1999 | -5.42x | $-1.78 Million | $-1.79 Million | $329.12K | ▼ -52.0% |
| 1998 | -3.57x | $-2.92 Million | $-3.04 Million | $817.91K | — |